AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-169982467/verona-rpl554-enters-toxicology.html" title="Facts and information about Verona's RPL554 enters toxicology study.(Verona Pharma Plc.)(Brief article)">Verona's RPL554 enters toxicology study.(Verona Pharma Plc.)(Brief article)</a>
Close
Set up an RSS feed that alerts you when new articles from Pharma Marketletter are available.
Frequently asked questions about RSS feeds
Verona's RPL554 enters toxicology study.(Verona Pharma Plc.)(Brief article)
UK-based Verona Pharma says that its novel anti-asthmatic compound, RPL554, is now entering a 28-day experimental inhalation toxicology study to demonstrate safety, before moving onto a proof-of-concept clinical trials early next year.
Verona Pharma adds that it is aiming to exploit a major opportunity in the $20.0 billion respiratory market with this compound, noting that many of today's drugs for asthma have unwanted side-effects and/or limited effectiveness.
RPL554 was invented by Sir ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- AIM-Quoted Verona Pharma Progresses Anti-Asthma Drug Studies.
- Press release article from: PR Newswire November 6, 2007 700+ words
...discovery company Verona Pharma is pleased to announce...experimental inhalation toxicology study in another species...limited effectiveness. Verona Pharma is aiming to exploit...drugs already in use. Verona Pharma has acquired the intellectual...
- VERONA PHARMA PLC - Clinical Trial Update.
- Press release article from: PR Newswire UK Disclose May 20, 2009 700+ words
20 May 2009 Verona Pharma plc ("Verona Pharma" or the "Company") First two stages of RPL554 Phase...Positive Results Approval to proceed to final stage of trial Verona Pharma, the AIM-quoted drug discovery company, is pleased...
- VERONA PHARMA PLC - Board Appointment.
- Press release article from: PR Newswire UK Disclose September 11, 2009 700+ words
11 September 2009 Verona Pharma plc ("Verona Pharma" or the "Company") Board Appointment The Board of Verona Pharma, the drug discovery company, is pleased to announce the appointment of Dr Patrick P. A. Humphrey, B.Pharm. Hons, Ph...
- VERONA PHARMA PLC - RPL554 proven safe and effective in patients with asthma.
- Press release article from: PR Newswire UK Disclose September 11, 2009 700+ words
11 September 2009 Verona Pharma plc ("Verona Pharma" or the "Company") A single dose of RPL554 is safe and effective in patients with asthma Verona Pharma plc, the AIM-quoted drug discovery company, announces...
- VERONA PHARMA PLC - Half-yearly Report.
- Press release article from: PR Newswire UK Disclose September 4, 2009 700+ words
4 September 2009 Verona Pharma plc ("Verona Pharma" or the "Company") INTERIM RESULTS FOR THE SIX MONTHS TO 30 JUNE 2009 The Board of Verona Pharma, the drug discovery company, is pleased to announce...
- Verona Pharma Signs Deal to Start Pre-clinical Studies on Ground Breaking Hay...
- Press release article from: PR Newswire June 4, 2007 700+ words
...FirstCall/ -- The life-sciences company Verona Pharma plc., has signed a contract with LAB Research...creating a medical need in this market that Verona Pharma is working to meet. Verona Pharma's CEO, Professor Michael Walker, commented...
- VERONA PHARMA PLC - Further re Board Appointment.
- Press release article from: PR Newswire UK Disclose September 11, 2009 700+ words
11 September 2009 Verona Pharma plc ("Verona Pharma" or the "Company") Further re: Board Appointment...Humphrey's option has been determined at 17.5 pence per Verona Pharma ordinary share. --END-- For more information please...
- VERONA PHARMA PLC - Result of AGM.
- Press release article from: PR Newswire UK Disclose May 22, 2009 700+ words
22 May 2009 Verona Pharma plc ("Verona Pharma" or the "Company") Result of AGM The Board of Verona Pharma, the drug discovery company, announces that at the Company's Annual General Meeting held earlier today, all resolutions were duly...